Mark David Brazeal Sells 25,000 Shares as Avgo Stock Rises

Mark David Brazeal sold 25,000 shares for $9.48 million as AVGO stock rose 4.8% on July 8 and disclosures followed on July 10.

Published
2 Min Read
8 Views
Mark David Brazeal Sells 25,000 Shares as Avgo Stock Rises

Mark David Brazeal sold 25,000 shares of AVGO stock on July 8 for about $9.48 million, while Broadcom shares rose 4.8% that day. He remained with 219,989 shares after the sale, according to his Form 4 disclosure filed with the SEC on July 10.

- Advertisement -

Gayla Delly Form 4

Gayla Delly also sold on July 8, disposing of 1,890 shares and receiving $728,368. Her sale reduced her stake by 5.69%, leaving her with 31,326 shares. Together, the two transactions pushed Broadcom executives past $10 million in stock sold on the day.

Broadcom and Apple partnership

The sales landed after Broadcom and Apple announced a $30 billion semiconductor partnership that runs through 2031. The agreement calls for Broadcom to manufacture more than 15 billion domestically-produced chips and includes Broadcom’s $1.5 billion commitment toward facility enhancements at its Fort Collins, Colorado manufacturing site.

For readers, that combination makes the trades harder to read in isolation. Insider sales can reflect personal portfolio management, but this set of filings arrived alongside a large partnership announcement and a single-day move that lifted AVGO to $399.97 from a wider 52-week range of $269.58 to $495.00.

TipRanks and analysts

TipRanks labeled the activity a Very Negative Insider Confidence Signal and said there were $26.6 million in informative sell transactions over the previous three-month period. That sits alongside a broadly positive analyst backdrop: William Blair’s Sebastien Naji kept a Buy recommendation, JPMorgan’s Harlan Sur reaffirmed a Buy rating, and Jefferies kept a Buy recommendation with a $550 price objective.

- Advertisement -

Erste Group moved the other way and shifted its stance to Hold. Broadcom’s June 3 quarterly report added to the backdrop, showing adjusted EPS of $2.44 and revenue of $22.19 billion, up 47.9% year over year. AVGO has also advanced nearly 16% since the start of the calendar year, which helps explain why the stock could absorb insider selling without losing its upward trend.

The immediate takeaway is simple: Brazeal’s sale was large, but it did not arrive in a vacuum. Investors watching AVGO now have the filings, the analyst split, and the Apple and Broadcom semiconductor partnership to weigh against each other as the market digests the latest disclosures.

Advertisement
TAGGED:
Share This Article
Investigative news reporter specialising in local government, public policy, and social issues. Two-time Regional Press Award winner.